Thrombocytopenia Secondary to Prophylactic Use of Ranitidine Hydrochloride

1996. Ranitidine Hydrochloride Monograph, Drug Information Handbook, Lexi-Comp Inc., pp. 1039-1041

1996. Ranitidine Hydrochloride Monograph, AHFS Drug Information , American Society of Health System Pharmacists, p 2182

Benichou, C. , Celigny, PS 1991. "Standardization of Definitions and Criteria for Causality Assessment of Adverse Drug Reactions, Drug Induced Cytopenias; Report of an International Consensus Meeting," Nouv Rev Fr Hematol, 33:257

Lebert, PA , MacLeod, SM and Mahon, WA, et al. 1981a. "Ranitidine Kinetics and Dynamics 1, Oral Dose Studies," Clin Pharmacol Ther., 30:539-544

1996. Product Information: Zantac®, Ranitidine Glaxo Pharmaceuticals, Research Triangle Park, NC

Aguro, ED , Vila, E. and Peterson, FB, et al. 1988. "The Use of Ranitidine in Bone Marrow Transplantation," Transplantation, 46:53-56

Jack, D. , Smith, RN and Wise, PJ 1984. "Ranitidine (letter," New England J Med. , 310:1606.

Shields, LI , Files, JA and Doll, DC 1986. "Ranitidine and Agranulocytosis," Ann Intern Med., 104:128

Brenner, LO 1986 "Agranulocytosis and Ranitidine (letter," Ann Int. Med, 104.896

Bader, A. , Carrigan, T. and Gopalswamy, N., et al. 1989. "Reversible Hematologic Suppression During Ranitidine Treatment (letter," DICP, 23:508-509

Gafter, U. , Zevin, D. and Komlos, L., et al. 1989. "Thrombocytopenia Associated with Hypersensitivity to Ranitidine: Possible Cross-Reactivity with Cimetidine ," Am. J Gastroenterol., 84:560-562